Looking for a specific product?

Make a search for products & suppliers, articles & news.

Early detection of Alzheimer’s and Parkinson’s

“Our objective is to make it possible to delay the onset and progression of dementia. This requires precise, early diagnosis,” says Tormod Fladby, Professor of Neurology at Oslo University Hospital.

Many countries involved

Professor Fladby heads the Norwegian segment of the project. Together with researchers from 20 other European countries, the Norwegians are working to refine the development of biomarkers for Alzheimer’s disease and Parkinson’s disease.

Postponing dementia: “Our objective is to make it possible to delay the onset and progression of dementia,” summarises Tormod Fladby. He is working on biomarkers from blood and cerebrospinal fluid to learn how these may provide evidence of pre-dementia stages and progression of Alzheimer’s disease, as measured by neuropsychological changes and MRI and PET scans. Photo: Siv Haugan Postponing dementia: “Our objective is to make it possible to delay the onset and progression of dementia,” summarises Tormod Fladby. He is working on biomarkers from blood and cerebrospinal fluid to learn how these may provide evidence of pre-dementia stages and progression of Alzheimer’s disease, as measured by neuropsychological changes and MRI and PET scans. (Photo: Siv Haugan)

Professor Fladby touts the advantages of this type of large-scale collaboration: “This gives us larger standardised patient populations, and all the researchers involved are using the same criteria throughout the entire joint project. This yields faster, more reliable conclusions than if we each had to work independently. Pulling together can make a huge difference!”

Treatment and care are demanding

“Medical treatment and care for dementia patients are very resource-intensive. So far there isn’t much available to help us to slow the progression of this group of diseases. But there are long interim phases before patients reach the stage of being greatly weakened and demented – which increases the chance of treatment before the severe damage occurs.”

“Early, precise diagnosis would enhance our understanding of disease progression before the dementia phase. If we could delay the onset of dementia diseases by five years, their incidence would be halved.”

Elderly man

This is a challenge that politicians as well as researchers in Europe are clearly concerned about. According to Professor Fladby, attention is being focused on diagnostics and the development of diagnostic methods, and there is a willingness to invest.

Demanding and rewarding

“Multinational collaboration like this unquestionably poses some difficult challenges. Routines, practices and available technology can vary widely between institutions and countries. But the positive outcomes and ripple effects are endlessly greater.”

Pofessor Fladby himself is working on biomarkers from blood and cerebrospinal fluid to learn how these may provide evidence of pre-dementia stages and progression of Alzheimer’s disease, as measured by neuropsychological changes and MRI and PET scans.

EU Joint Programming Initiative

The project Biomarkers for Alzheimer’s disease and Parkinson’s disease is a collaboration between neuroscience research groups specialising in nurology, psychiatry and geriatrics. Norwegian research groups from Tromsø, Bodø, Trondheim, Bergen, Stavanger and Oslo are involved.

JPND The project was awarded funding under the very first call for proposals issued by the EU Joint Programme - Neurodegenerative Disease Research (JPND), which is a Joint Programming Initiative (JPI).

 

Related news

Latest news

SAR Celebrates 2nd anniversary in Kuwait

SAR Celebrates 2nd anniversary of operation in Kuwait.

SAR AS Celebrates 30 years of operation!

The history of SAR goes 50 years back to the late 1960s with the company Septik Tank Co. 

Ready to conquer the world with Hansen Protection Helicopter pilot suits

In 2017, for the first time in the history of helicopter sport, the World Cup in Helicopter Races is going to be held. It is going to take place in 7 countries, and starts on Friday April 7th in Konakovo, Russia.

SeaBass Fisherman's Work / Flotation Suit

SeaBass is a waterproof, buoyant work suit for anyone working on or around water.

Improved Surface Rescue Preparedness can Save Lives

A significant part of the Norwegian fire and rescue services lack good apparel for use in surface rescue operations. This can mean the loss of valuable time in rescue operations in water, and experts now call for a change ...

Historical contract for Norwater AS!

The excitement was at its height at Norwater AS in Høylandsbygd on Wednesday last week. The company signed its biggest contract in history, in strong competition with both Norwegian and foreign competitors. The order book ...

Export Credit Norway Finances Production of Ready-to-use Therapeutic Foods in South Africa

Since being founded in 1948, the Norwegian company GC Rieber Compact has developed into a leading supplier of ready-to-use therapeutic foods to customers such as Doctors Without Borders, the Red Cross, the World Food Progr...

Peru Corporate Day

On 26th September, Oslo Chamber of Commerce will for the first time receive a technological business delegation from Peru to Norway, led by PROMPERÚ.

New contract for delivery of Servogear CPP

The Servogear installation includes CPP propellers,